WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1'0501 Infant (under 12 months) mortality rate: 452
GDP / capita (US$): 2'3121 Child (under 5 years) mortality rate: 602

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 14'548  14'133  13'726  13'331  12'951  9'862  7'514  5'569 
Births 543  534  524  513  502  396  328  271 
Surviving infants 517  508  498  487  476  370  304  246 
Pop. less than 5 years 2'440  2'379  2'313  2'249  2'189  1'684  1'388  1'087 
Pop. less than 15 years 6'319  6'149  5'977  5'809  5'651  4'449  3'540  2'601 
Female 15-49 years 3'540  3'439  3'343  3'248  3'154  2'299  1'626  1'199 

Number of reported case

(Click for retrospective incidence data for Senegal)
Diphtheria 291 
Japanese encephalitis
Measles 32  17  46  18  428  5'839  5'004  29'144 
Mumps
Pertussis 1'041  22'792 
Polio* 18  138 
Rubella 101  44  44  141  50 
Rubella (CRS)
Tetanus (neonatal) 14  21  12  67 
Tetanus (total)** 78  118  144  21  109  1'378 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Senegal)
Vaccine year result method % card seen                                                
BCG 2013  95  DHS   69  95  97  94  95  80  89  90 
DTP1 2013  96  DHS   69  94  96  94  80  79 
DTP3 2013  89  DHS   69  89  92  83  83  70  52  66 
DTP4         
IPV1         
HepB_BD         
HepB3 2013  89  DHS   69  89  92  83  83  70 
Hib3 2013  89  DHS   69  89  92  83  83  70 
JapEnc         
MCV1          80  84  82  82  60  48  57 
MCV2          13 
PCV1          94 
PCV3          81 
Pol3 2013  84  DHS   69  85  89  73  73  70  49  66 
Rota1         
Rota_last         
Rubella1          80  84 
TT2plus 2013  54  DHS   69  84  88  70  60  45  37 
PAB         
VAD1          88  68  60  60 
YFV 2012  77  DHS   71  80  83  82  81  60  34 
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Senegal)
BCG 95  97  97  97  97  89  90 
DTP1 94  96  96  97  96  79  75 
DTP3 89  92  91  92  89  52  51 
HepB3 89  92  91  92  89 
HepB_BD
Hib3 89  92  91  92  89 
MCV1 80  84  83  84  81  48  51 
MCV2 13 
PAB 91  91  91  88  88  62  45 
PCV3 81 
Pol3 85  89  83  89  76  49  53 
Rota_last
YFV 80  83  80  84  80  34 

Number of districts in the country 76  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
96 
   
/
|
|
\
Greater or equal to 90% 34
From 80 to 89% 24
From 50 to 79% 26
Less than 50% 16
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 9 years; +6 months; girls of 9 years
MR 9,15 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
Td 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
VitaminA 6, 12, 18, 24, 30, 36 months; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016    2013-2017  2012-2016  2007-2011  2007 - 2011  2007 - 2011 
Nº of districts with microplans that include activities to raise immunization coverage number 76  76  76  75  65  65  65 

System performance

Total Nº districts in country number 76  76  76  75  65  65  65 
Nº districts with DTP3 coverage >=80% number 44  24  46  44 
% of districts with DTP3 coverage >=80% From 0 to 100% 58  32  71  68 
Nº districts with measles (MCV1) coverage >=95% number 13     
% of districts with MCV1 coverage >=95% From 0 to 100% 17  11     

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 15  30  20  100  28  80 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  No  No  No     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.